Literature DB >> 2979273

The effect of food on ranitidine-induced inhibition of nocturnal gastric secretion.

D A Johnston1, K G Wormsley.   

Abstract

Overnight gastric secretion of acid and pepsin was studied in nine, healthy, male volunteers on two separate occasions, in randomized order. On one day, each individual received a standard meal at 18.00 hours, followed by an oral dose of 300 mg ranitidine at 18.15 hours. During the second study, 300 mg ranitidine was again taken at 18.15 hours, but the meal was consumed at 22.00 hours. Gastric juice was sampled hourly from 19.00 to 24.00 hours and then aspirated completely and continuously until 08.00 hours the next morning. Median pH values were significantly lower and median acidity was significantly higher, when the meal was eaten at 22.00 hours. The outputs of acid and pepsin after midnight were also significantly greater following the late night meal. It seems that food interferes with the gastric inhibitory effects of the currently used H2-receptor antagonists, such as ranitidine. We conclude that H2-receptor antagonists must be taken after the last meal of the day in order to ensure maximal therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2979273     DOI: 10.1111/j.1365-2036.1988.tb00724.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

1.  pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.

Authors:  C H Wilder-Smith; F Halter; W Häcki; H S Merki
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

2.  Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH.

Authors:  T G Reilly; S G Mann; M Z Panos; R P Walt
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing.

Authors:  G Bianchi Porro; F Parente; O Sangaletti
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

Review 4.  Pharmacokinetics and pharmacodynamics of H2-receptor antagonists in patients with renal insufficiency.

Authors:  U Gladziwa; U Klotz
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

5.  Circadian pattern of intragastric acidity in duodenal ulcer patients: a study of variations in relation to ulcer activity.

Authors:  S Wagner; U Gladziwa; M Gebel; A Schüler; J Freise; F W Schmidt
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

Review 6.  Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure.

Authors:  U Gladziwa; U Koltz
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

7.  Postprandial biliary and pancreatic secretion during profound inhibition of gastric secretion in humans.

Authors:  A Lanzini; D Facchinetti; M G Pigozzi; A Wuhrer; A Saleri
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.